Policy Watch. New models support comparative research, more nonprescription drugs.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 237
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 2012 AND VI 47 AND IP 6
Results: 10
1
2
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 210
- Publication type:
- Article
3
Medication Safety and Reliability. FDA warns of new malignancies with multiple myeloma treatment.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 227
- By:
- Publication type:
- Article
4
Medication Safety and Reliability. New contraindications and modified cardiovascular monitoring parameters for fingolimod.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 227
- Publication type:
- Article
5
Liposomal bupivacaine: A long-acting local anesthetic for postsurgical analgesia.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 212
- By:
- Publication type:
- Article
6
Expansion paradigm of nonprescription drugs could improve efficiencies and access, but raises Quality issues.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 211
- By:
- Publication type:
- Article
7
Management of chronic kidney disease: An emphasis on delaying disease progression and treatment options.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 228
- By:
- Publication type:
- Article
8
FDA Drug Approvals. First-time generic approval.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 210
- Publication type:
- Article
9
FDA Drug Approvals. New molecular entities.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 209
- Publication type:
- Article
10
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 6, p. 209
- Publication type:
- Article